Evidence map›Paper›PMID 41429999›Full record

ReviewJournal of materials science. Materials in medicine2025

Recent progress of NIR light-controlled microneedles and therapeutic applications: A review study.

Nafiseh Farhadian, Reza Abachizadeh, Shaghayegh Kouhestani

Abstract readReview
In one paragraph

Review in Journal of materials science. Materials in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nafiseh FarhadianChemical Engineering Department, Faculty of Engineering, Ferdowsi University of Mashhad, Mashhad, Iran. n.farhadian@um.ac.ir.
Reza AbachizadehChemical Engineering Department, Faculty of Engineering, Ferdowsi University of Mashhad, Mashhad, Iran.
Shaghayegh KouhestaniChemical Engineering Department, Faculty of Engineering, Ferdowsi University of Mashhad, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transdermal drug delivery presents an appealing alternative to traditional administration methods like oral and injection routes, as it circumvents first-pass metabolism, minimizes pain and infection risks, and enhances patient compliance. Nonetheless, the skin barrier remains a significant obstacle to delivering most medications through the skin. Microneedles (MNs) represent an innovative technology that can address this issue by forming tiny pores in the skin, facilitating the transport of drugs or biomolecules. MNs are manufactured from various materials and come in different designs and classifications. They can also be activated by external stimuli, such as near-infrared (NIR) light, which excels over other light types for this application due to its deeper tissue penetration, allowing for on-demand and precise temporal drug delivery. This review primarily concentrates on NIR light-controlled MNs, which respond to NIR light exposure to release drugs. Here, the fundamental concepts and mechanisms behind NIR light-controlled MNs are introduced, which utilize NIR light-sensitive materials or devices that alter their properties or functions in response to NIR light exposure. Benefits and difficulties associated with NIR light-controlled MNs, such as their extensive penetration capability, low toxicity, and accurate control, are examined. The potential for integrating NIR light-controlled MNs with other therapeutic strategies to boost their efficacy will be investigated. Recent advancements and applications of NIR light-controlled MNs in diverse areas, including diabetes management, cancer therapy, and wound healing, are reviewed. Finally, the future directions for their application will be addressed.

Indexed as

Drug Delivery SystemsInfrared RaysMicroinjectionsNeedlesAdministration, CutaneousAnimalsEquipment DesignHumansSkin

Identifiers

PMID41429999
PMCPMC12783163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.